Back to search

Article

HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria

2022-04-01

Abstract excerpt

<title>Abstract</title> <p><bold>Objective: </bold>Although HER2 has gradually become an important therapeutic target for colorectal cancer (CRC), a unified and standard HER2 scoring system was still not established in CRC, and the debatable results of immunohistochemistry and fluorescence in situ hybridization (FISH) in CRC requires further exploration.<bold>Methods:</bold> In this study, we use five immunohisto...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3a7d571b-8777-5d16-8328-39979ffc7de0
DOI
10.21203/rs.3.rs-1475886/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteriaDOI 10.21203/rs.3.rs-1475886/v1
HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic SchemesSemantic proximity
Different Clinicopathological Characteristics in Indonesian Colorectal Patients with NRAS Mutations and HER2 ExpressionSemantic proximity
Genomic profiling of colorectal cancer in large-scale Chinese patients: amplification and somatic mutations in ERBB2.Semantic proximity
International Harmonization of Provisional Diagnostic Criteria for ERBB2-Amplified Metastatic Colorectal Cancer Allowing for Screening by Next-Generation Sequencing PanelSemantic proximity
HER2 expression and relevant clinicopathological features in esophageal squamous cell carcinoma in a Chinese populationSemantic proximity
HER2 in Colorectal Carcinoma: Are We There yet?Semantic proximity
A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer.Semantic proximity
HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials.Semantic proximity
Investigating incidence of RAS/RAF and PIK3CA alterations in HER2-amplified colorectal cancer: a comprehensive analysis.Semantic proximity
HER2 Amplification and PD-L1 Expression in Advanced Gastric Cancer: Correlations, Clinical Implications, and Molecular CharacteristicsSemantic proximity
Different Clinicopathological Characteristics in Indonesian Colorectal Patients with NRAS Mutations and HER2 Over-Expression.Semantic proximity
Updated 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) guideline recommendations for human epidermal growth factor receptor 2 (HER2) fluorescent in situ hybridization (FISH) testing increase HER2 positive and HER2 equivocal breast cancer cases; retrospective study of HER2 FISH results of 836 invasive breast cancersSemantic proximity
Select a neighboring publication to make it the new centre.